1. Home
  2. SUPN vs EVTC Comparison

SUPN vs EVTC Comparison

Compare SUPN & EVTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SUPN
  • EVTC
  • Stock Information
  • Founded
  • SUPN 2005
  • EVTC 1988
  • Country
  • SUPN United States
  • EVTC United States
  • Employees
  • SUPN N/A
  • EVTC N/A
  • Industry
  • SUPN Biotechnology: Pharmaceutical Preparations
  • EVTC EDP Services
  • Sector
  • SUPN Health Care
  • EVTC Technology
  • Exchange
  • SUPN Nasdaq
  • EVTC Nasdaq
  • Market Cap
  • SUPN 2.0B
  • EVTC 2.1B
  • IPO Year
  • SUPN 2012
  • EVTC 2013
  • Fundamental
  • Price
  • SUPN $42.00
  • EVTC $37.11
  • Analyst Decision
  • SUPN Buy
  • EVTC Hold
  • Analyst Count
  • SUPN 2
  • EVTC 5
  • Target Price
  • SUPN $41.00
  • EVTC $39.00
  • AVG Volume (30 Days)
  • SUPN 1.0M
  • EVTC 346.5K
  • Earning Date
  • SUPN 08-05-2025
  • EVTC 07-30-2025
  • Dividend Yield
  • SUPN N/A
  • EVTC 0.54%
  • EPS Growth
  • SUPN 1411.53
  • EVTC 102.95
  • EPS
  • SUPN 1.14
  • EVTC 2.13
  • Revenue
  • SUPN $665,125,000.00
  • EVTC $886,589,000.00
  • Revenue This Year
  • SUPN N/A
  • EVTC $7.87
  • Revenue Next Year
  • SUPN $15.74
  • EVTC $5.05
  • P/E Ratio
  • SUPN $37.58
  • EVTC $17.35
  • Revenue Growth
  • SUPN 5.55
  • EVTC 12.93
  • 52 Week Low
  • SUPN $29.16
  • EVTC $31.11
  • 52 Week High
  • SUPN $43.73
  • EVTC $38.56
  • Technical
  • Relative Strength Index (RSI)
  • SUPN 69.63
  • EVTC 61.05
  • Support Level
  • SUPN $40.26
  • EVTC $36.57
  • Resistance Level
  • SUPN $43.73
  • EVTC $37.71
  • Average True Range (ATR)
  • SUPN 1.80
  • EVTC 0.73
  • MACD
  • SUPN 0.31
  • EVTC 0.30
  • Stochastic Oscillator
  • SUPN 84.13
  • EVTC 82.81

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. It derives maximum revenue from Latin America Payments and Solutions. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

Share on Social Networks: